BEV-IP: Perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis

BACKGROUND: Selected patients with peritoneal carcinomatosis (PC) from colorectal cancer (CRC) benefit from cytoreductive surgery (CRS) combined with intraperitoneal chemoperfusion (IPC). However, even after optimal cytoreduction, systemic and locoregional recurrence are common. Perioperative chemot...

Descripción completa

Detalles Bibliográficos
Autores principales: Willaert, Wouter, Van Der Speeten, Kurt, Liberale, Gabriel, Ceelen, Wim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682259/
https://www.ncbi.nlm.nih.gov/pubmed/26673788
http://dx.doi.org/10.1186/s12885-015-1954-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682259/
https://www.ncbi.nlm.nih.gov/pubmed/26673788
http://dx.doi.org/10.1186/s12885-015-1954-x

Ejemplares similares